Rising drug prices are contributing to hospitals' increased costs of delivering care.
Read More
More bad news for the hospital readmission reduction program, as a new study in Health Affairs concludes that it had far less effect than previously estimated.
Read More
The annual ECRI Institute list of health safety hazards is out.
Read More
A McKinsey post addresses issues around patient adherence to treatment regimens.
Read More
A study in Health Affairs finds that "digital" health companies provide little value for the populations that likely need the most help.
Read More
An evaluation of the first two years of the mandatory joint replacement episode payment program in Medicare found minor spending reductions and no effect on quality.
Read More
Research carried by Health Affairs purports to find that health care spending for certain conditions is cost-effective.
Read More
Research carried in Health Affairs looks at persistently high-cost Medicare patients.
Read More
The National Venture Capital Association gives us data on financings and exits for the fourth quarter and full year of 2018.
Read More
A study in JAMA reviews the association between cost-sharing, medication adherence and medical outcomes.
Read More
An article in Health Affairs once again tries to reinforce the point that the health spending issue in the US is due to prices, not utilization.
Read More
The Journal of the American Medical Association has a lengthy analysis of medical product marketing spending over the last two decades.
Read More
The American Hospital Association claims hospitals are grossly underpaid by Medicare and Medicaid.
Read More
The latest volley in the 340B program wars comes from the drug industry and not surprisingly finds that hospital participation raises use and spending.
Read More
JAMA carries a meta-review of interventions to improve adherence to drug regimens.
Read More